Jyothy Laboratories Ltd. said its normalized net income for the fiscal fourth quarter ended March 31 came to 1.57 Indian rupees per share, compared with the S&P Capital IQ consensus estimate of 2.61 rupees per share.
EPS climbed 84.0% year over year from 85 paise.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 288.0 million rupees, a gain of 84.7% from 155.9 million rupees in the year-earlier period.
The normalized profit margin increased to 9.9% from 3.9% in the year-earlier period.
Total revenue rose 12.4% year over year to 4.45 billion rupees from 3.96 billion rupees, and total operating expenses climbed 7.1% year over year to 3.91 billion rupees from 3.66 billion rupees.
Reported net income increased 31.0% year over year to 355.4 million rupees, or 1.94 rupees per share, from 271.3 million rupees, or 1.48 rupees per share.
For the year, the company's normalized net income totaled 6.42 rupees per share, compared with the S&P Capital IQ consensus normalized EPS estimate of 8.68 rupees.
EPS rose 57.2% from 4.09 rupees in the prior year.
Normalized net income was 1.18 billion rupees, a gain of 58.3% from 744.5 million rupees in the prior year.
Full-year total revenue rose 9.3% year over year to 16.45 billion rupees from 15.06 billion rupees, and total operating expenses increased 5.6% on an annual basis to 14.55 billion rupees from 13.78 billion rupees.
The company said reported net income increased 30.3% on an annual basis to 1.58 billion rupees, or 8.60 rupees per share, in the full year, from 1.21 billion rupees, or 6.65 rupees per share.
As of June 23, US$1 was equivalent to 67.39 Indian rupees.